Background Image
Table of Contents Table of Contents
Previous Page  30 / 76 Next Page
Information
Show Menu
Previous Page 30 / 76 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 1, January/February 2017

28

AFRICA

all participants. Due to insufficient funds, we were not able to

compare EndoPAT results with a blood marker of endothelial

dysfunction, but such a study is planned.

Conclusion

This study has shown that there is impaired endothelial function

in rural African women with pre-eclampsia, based on the

low RHI and increased arterial stiffness, as measured by the

BPWA and augmentation index, compared to normotensive

pregnancies. This clearly indicates that RHI, BPWA and

Alx@75, as measured using the EndoPAT, can be used for

assessing endothelial dysfunction in pre-eclampsia. Although

PAT could be used as an adjunct to blood pressure measurement

in assessing patients with pre-eclampsia, the EndoPAT is a

relatively expensive piece of equipment.

The EndoPAT 2000 may earn its worth if it could detect

endothelial dysfunction and hence be used for screening patients

before the onset of hypertension and proteinuria. This will need

to be assessed in a prospective, cohort study of pregnant women

from the first or early second trimester until delivery, in order

to determine whether a reduced RHI can be detected before the

onset of pre-eclampsia. Such a study is planned.

References

1.

World Health Organisation, 2010. Trends in maternal mortality: 1990 to

2008. Estimates developed by WHO, UNICEF, UNFPA and The World

Bank.

http://www.apps.who.int.

2.

Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM,

et al

. Maternal mortality for 181 countries, 1980–2008: a systematic

analysis of progress toward millennium development goal 5.

Lancet

2010;

375

: 1609–1623. PMID: 20382417.

3.

Warrington JP, George EM, Palei AC, Spradley FT, Granger JP. recent

advances in the understanding of the pathophysiology of preeclampsia.

Hypertension

2013;

62

: 666–673. PMID: 3856636.

4.

Deanfiled JE, Donald A, Ferri C, Giannnattasio C, Halcox C, Halligan

S,

et al

. Endothelial function and dysfunction. Part 1: Methodological

issues for assessment in the different vascular beds; a statement by the

working group on Endothelin and endothelial factors of the European

Society of hypertension.

J Hypertens

2005;

23

: 7–17. PMID: 15643116.

5.

Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.

Maternal endothelial function and serum concentrations of placental

growth factor and soluble endoglin in women with abnormal placenta-

tion

Ultrasound Obstet Gynecol

2008;

32

: 871–876. PMID: 18814185.

6.

Aizer J, Karlson EW, Chibnik LB, Costenbader KH, Post D, Liang MH,

et al

. Controlled comparison of brachial artery flow mediated dilation

(FMD) and digital pulse amplitude tonometry (PAT) in the assessment

of endothelial function in systemic lupus erythematosus.

Lupus

2009;

18

(3): 235–242. PMCID: PMC2754753.

7.

Lee S, Kevin KM. Velocity acceleration as a determinant of flow medi-

ated dilatation.

Ultrasound Med Bio

2012;

38

: 1–13. PMID: 22342687.

8.

Allan RB, Delaney CL, Millar MD, Spark JI. A comparison of flow-

mediated dilatation and peripheral artery tonometry for measurement

of endothelial function in healthy individuals and patients with periph-

eral arterial disease.

Eur J Vasc Endovasc Surg

2013;

45

(3): 263–269.

PMID 23321336.

9.

Saarelainen H, Kärkkäinen H, Valtonen P, Punnonen K, Laitinen T,

Heiskanen N,

et al

. Clinical Study Flow-Mediated Vasodilation Is Not

Attenuated in Hypertensive Pregnancies Despite Biochemical Signs

of Inflammation.

International Scholarly Research Network ISRN

Obstetrics and Gynecology

2012; 2012: 1–6. PMCID: PMC3302009.

10. Fujita K, Tatsumi K, Kondoh E, Chigusa Y, Mogami H, Fujita M,

et

al

. Endothelial function progressively deteriorates during normal preg-

nancy.

Hypertens Pregnancy

2013;

32

(2): 129–138. PMID: 23725078.

11. Hamburg NM, Keyes MJ, Larson MG. Cross-sectional relations of digi-

tal vascular function to cardiovascular risk factors in the Framingham

Heart Study.

Circulation

2008;

117

:2467–2474. PMID: 18458169.

12. Schroeter H, Heiss C, Balzer J. Epicatechin mediates beneficial effects of

flavanol-rich cocoa on vascular function in humans.

Proc Natl Acad Sci

USA

2006;

103

: 1024–1029. PMID: 16418281.

13. Aversa A, Vitale C, Volterrani M. Chronic administration of sildenafil

improves markers of endothelial function in men with type 2 diabetes.

Diabet Med

2008;

25

: 37–44. PMID: 18199130.

14. Haller MJ, Stein J, Shuster J. Peripheral artery tonometry demonstrates

altered endothelial function in children with type 1 diabetes.

Pediatr

Diabetes

2007;

8

: 193–198. PMID: 17659060.

15. Carty DM. Preeclampsia; early prediction and long-term consequences

.

PhD thesis: University of Glasgow; 2012.

http://theses.gla.ac.uk/3124/.

16. Kuvin JT, Patel AR, Sliney KA. Assessment of peripheral vascular

endothelial function with finger arterial pulse wave amplitude.

Am Heart

J

2003;

146

:168–174. PMID: 12851627.

17. Yinon D, Lowenstein L, Suraya S. Preeclampsia is associated with sleep-

disordered breathing and endothelial dysfunction.

Eur Respir J

2006;

27

:328–333. PMID: 16452588

18. Yoshida A, Nakao S, Kobayashi M, Kobayashi H. Flow-mediated vaso-

dilation and plasma fibronectin levels in pre-eclampsia.

Hypertension

2000;

36

: 400-404. PMID: 10988272

19. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner

JS. Association of maternal endothelial dysfunction with preeclampsia.

JAMA

2001

;

285

: 1607–1612. PMID: 11268269

20. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.

Prospective study of placental angiogenic factors and maternal vascular

function before and after pre-eclampsia and gestational hypertension.

Circulation

2010;

122

:478-487. PMID: 20644016

21. Cross JC. The genetics of preeclampsia: a feto-placental or maternal

problem?

Clin Genet

2003;

64

:96–103. PMID: 12859402

22. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late pre-

eclampsia: two different maternal hemodynamic states in the latent

phase of the disease.

Hypertension

2008;

52

:873–880. PMID: 18824660

23. Thijssen DH, Dawson EA, Black MA, Hopman MT, Cable NT, Green

DJ. Heterogeneity in conduit artery function in humans: impact of

arterial size.

Am J Physiol Heart Circ Physiol

2008

;

295

: H1927–1934.

PMID: 18775852

24. Heffernan KS, Karas RH, Mooney PJ, Patel, Kuvin JT. Pulse wave

amplitude is associated with brachial artery diameter: implications for

gender differences in microvascular function.

Vasc Med

2010

;

15

(1):

39–45. PMCID: PMC2914458.

25. Praciano P, Alves JA, Bezerra S, Costa FD. Brachial artery flow-mediated

dilatation as a predictor of preeclampsia in the second trimester of

pregnancy. 23rd World Congress on Ultrasound in Obstetrics and

Gynecology 2013

.

Short oral presentation abstracts. DOI: 10.1002/

uog.12783.

26. Alves AG, Brennecke SP, da Silva Costa F. Brachial artery flow-medi-

ated dilatation as a predictor of preeclampsia in the first trimester of

pregnancy.

Pregnancy Hypertens

2012;

2

(3): 217–218. PMID: 26105287.

27. Yoshida A, Nakao S, Kobayashi M, Kobayashi H. Noninvasive assess-

ment of flow-mediated vasodilation with 30-MHz transducer in preg-

nant women.

Hypertension

1998;

31

: 1200–120. PMID: 9576136.

28. Truschel E, Jarczok MN, Fischer JE, Terris DD. High throughput